An Open-Label, Multicenter Study to Evaluate the Safety/Tolerability and Clinical Utility of Low-Dose TTS-Fentanyl D-TRANS in Taiwan Patients With Cancer Pain.

Trial Profile

An Open-Label, Multicenter Study to Evaluate the Safety/Tolerability and Clinical Utility of Low-Dose TTS-Fentanyl D-TRANS in Taiwan Patients With Cancer Pain.

Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Oct 2014

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Cancer pain
  • Focus Adverse reactions
  • Sponsors Johnson & Johnson
  • Most Recent Events

    • 01 Jul 2009 Actual end date (Nov 2008) added as reported by ClinicalTrials.gov.
    • 01 Jul 2009 Actual initiation date (Oct 2008) added as reported by ClinicalTrials.gov.
    • 01 Jul 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top